Tatsuya Sato

Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts

Masashi Mizuno, Atsushi Kuno, Toshiyuki Yano et al. · Physiological Reports · 2018 · 165 citations · Full text

Heart Failure, Lipid Droplets, Mitochondrial Size +19

Reduction in mitochondrial iron alleviates cardiac damage during injury

Hsiang‐Chun Chang, Rongxue Wu, Meng Shang et al. · EMBO Molecular Medicine · 2016 · 137 citations · Full text

Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats

H Oshima, Takayuki Miki, Atsushi Kuno et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 119 citations · Full text

mRNA-binding protein tristetraprolin is essential for cardiac response to iron deficiency by regulating mitochondrial function

Tatsuya Sato, Hsiang‐Chun Chang, Marina Bayeva et al. · Proceedings of the National Academy of Sciences · 2018 · 86 citations · Full text

mTORC1 inhibition attenuates necroptosis through RIP1 inhibition-mediated TFEB activation

Koki Abe, Toshiyuki Yano, Masaya Tanno et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2019 · 77 citations · Full text

Mitophagy, Apoptosis, Immunology +17